Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007
Effect of theophylline on matrix metalloproteinase-9 in induced sputum in the elderly patients with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003
Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Effect of salmeterol in asthmatic patients with low sputum eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002
The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Correlation between ECP in induced sputum and asthma symptoms in children treated with budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 450s Year: 2001
Inhibitory effects of budesonide and formoterol in combination on TGFβ-induced proteoglycan production by bronchial biopsy fibroblasts from healthy and mild asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Polymoprhisms in the MMP-9 and TIMP-1 genes in an Australian asthmatic and non-asthmatic population Source: Eur Respir J 2003; 22: Suppl. 45, 581s Year: 2003
The effect of nedocromil and montelukast on IL-10 serum level in children with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001
Relationship between sputum level of matrix metallopreteinase (MMP-9)/tissue inhibitor of metalloproteinase (TIMP-1) and methacholine bronchial hyper-reactivity in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019
The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Inhaled corticosteroids only decrease on the lymphocytes PGP expression and antileukotrienes mrp expression in asthmatic children after one month treatment Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007